Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 22 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Gleolan For Visualization Of Newly Diagnosed Or Recurrent Ovarian Cancer (OVA-302)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

    Jacksonville, FL

  4. Testing Olaparib For One Or Two Years, With Or Without Bevacizumab, To Treat Ovarian Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Gemini Study To Evaluate The Integration Of Cancer Genetic Testing Into A Cancer Clinical Practice At Mayo Clinic At Arizona

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood In Patients With Relapsed And Resistant Ovarian Cancer

    Scottsdale/Phoenix, AZ

  7. CATALINA-4: A Study To Investigate The Safety And Efficacy Of TORL-1-23 With Chemotherapy Given Before Initial Surgery In Women With Advanced Stage Ovarian Cancer

    Rochester, MN

  8. Broad Evidence Of Systemic Immune Activation In Long Term Survivors Of Advanced Ovarian Cancer

    Jacksonville, FL, Rochester, MN

  9. Changes In Blood Components In Patients With Ovarian Cancer

    Rochester, MN

  10. Establishment Of Preclinical Models From Patients With Gynecological Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer